Genelux Corp Files 8-K with Material Agreement

Ticker: GNLX · Form: 8-K · Filed: May 24, 2024 · CIK: 1231457

Genelux Corp 8-K Filing Summary
FieldDetail
CompanyGenelux Corp (GNLX)
Form Type8-K
Filed DateMay 24, 2024
Risk Levelmedium
Pages5
Reading Time6 min
Key Dollar Amounts$0.001, $5.25, $4.00, $25.4 m, $5
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, corporate-event

Related Tickers: GENLUX

TL;DR

GENLUX filed an 8-K on 5/23/24, looks like a material agreement is in play.

AI Summary

On May 23, 2024, Genelux Corporation entered into a Material Definitive Agreement, the details of which are not fully disclosed in this filing. The company also provided a Regulation FD Disclosure and reported on Other Events. The filing includes financial statements and exhibits related to these events.

Why It Matters

This 8-K filing indicates significant corporate activity for Genelux Corporation, potentially impacting its business operations and investor outlook.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement, which could represent significant opportunities or risks for the company, but specific details are not yet public.

Key Players & Entities

  • Genelux Corporation (company) — Registrant
  • May 23, 2024 (date) — Date of earliest event reported

FAQ

What is the nature of the Material Definitive Agreement entered into by Genelux Corporation?

The filing states that Genelux Corporation entered into a Material Definitive Agreement on May 23, 2024, but the specific terms and details of this agreement are not disclosed in this particular 8-K filing.

What are the key items reported in this 8-K filing?

This 8-K filing reports on the entry into a Material Definitive Agreement, a Regulation FD Disclosure, Other Events, and includes Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on May 23, 2024.

What is Genelux Corporation's state of incorporation and fiscal year end?

Genelux Corporation is incorporated in Delaware and its fiscal year ends on December 31.

What is the principal executive office address for Genelux Corporation?

The principal executive offices of Genelux Corporation are located at 2625 Townsgate Road, Suite 230, Westlake Village, California, 91361.

Filing Stats: 1,467 words · 6 min read · ~5 pages · Grade level 11.8 · Accepted 2024-05-24 08:11:19

Key Financial Figures

  • $0.001 — ch registered Common stock, par value $0.001 per share GNLX The Nasdaq Stock Mar
  • $5.25 — "Warrants"), with an exercise price of $5.25 per share, at a combined offering price
  • $4.00 — share, at a combined offering price of $4.00 per share and accompanying Warrant. Und
  • $25.4 m — fering are expected to be approximately $25.4 million, after deducting the underwriting
  • $5 — an initial exercise price per share of $5.25, subject to certain adjustments as p

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Genelux Corporation Date: May 24, 2024 By: /s/ Thomas Zindrick, J.D. Thomas Zindrick, J.D. President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.